Literature DB >> 1060098

Neurohypophyseal hormones, analogs, and fragments: their effect on puromycin-induced amnesia.

R Walter, P L Hoffman, J B Flexner, L B Flexner.   

Abstract

Neurohypophyseal hormones and several of their analogs, as well as N-terminal and C-terminal fragments, have been studied for their ability to attenuate puromycin-induced amnesia in mice. [8-Lysine]vasopressin, [8-arginine]vasopressin, and the analogs des-9-glycinamide-[8-lysine]vasopressin, [1-beta-mercaptopropionic acid, 8-lysine]vasopressin, [1,6-aminosuberic acid, 8-lysine]vasopressin, [4-leucine, 8-lysine]vasopressin, glycyl-glycyl-glycyl-[8-lysine]vasopressin, [1-beta-mercaptopropionic acid, 8-D-arginine]vasopressin, and [1,6-aminosuberic acid, 8-arginine]vasopressin are active. [8-Arginine]oxytocin as well as oxytocin and all of its other analogs tested are inactive with the striking exception of glycyl-glycyl-glycyl-oxytocin. The structural aspects of the neurohypophyseal hormones which appear to be important for significant activity in memory consolidation include the combination of a cyclic moiety containing the Tyr and Phe residues along with a basic residue in position 8. Another series of active compounds comprises C-terminal neurohypophyseal peptides and analogs thereof, including the naturally occurring Pro-Leu-Gly-NH2 and, most surprisingly, Leu-Gly-NH2, as well as its derivatives D-Leu-Gly-NH2 and the diketopiperazine, cyclo(-Leu-Gly-).

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1060098      PMCID: PMC433164          DOI: 10.1073/pnas.72.10.4180

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  50 in total

1.  RENAL EXCRETION AND TISSUE DISTRIBUTION OF RADIOACTIVITY AFTER ADMINISTRATION OF TRITIUM-LABELED OXYTOCIN TO RATS.

Authors:  J P AROSKAR; W Y CHAN; J E STOUFFER; C H SCHNEIDER; V V MURTI; V DUVIGNEAUD
Journal:  Endocrinology       Date:  1964-02       Impact factor: 4.736

2.  Synthesis and biological properties of 1-desamino-8-lysine-vasopressin.

Authors:  R D KIMBROUGH; W D CASH; L A BRANDA; W Y CHAN; V DU VIGNEAUD
Journal:  J Biol Chem       Date:  1963-04       Impact factor: 5.157

3.  Effect of magnesium ion on the response of the rat uterus to neurohypophysial hormones and analogues.

Authors:  R A MUNSICK
Journal:  Endocrinology       Date:  1960-03       Impact factor: 4.736

4.  Differences in the antidiuretic responses of rats to the intravenous administration of lysine and arginine vasopressins.

Authors:  W H SAWYER
Journal:  Endocrinology       Date:  1958-11       Impact factor: 4.736

5.  'Hormonogen' analogues of lysine vasopressin: rat pressor and antidiuretic activities.

Authors:  J Kyncl; K Rezábek; E Kasafírek; V Pliska; J Rudinger
Journal:  Eur J Pharmacol       Date:  1974-10       Impact factor: 4.432

6.  Conformation of lysine vasopressin: a comparison with oxytocin.

Authors:  R Walter; J D Glickson; I L Schwartz; R T Havran; J Meienhofer; D W Urry
Journal:  Proc Natl Acad Sci U S A       Date:  1972-07       Impact factor: 11.205

7.  Localized behavioral effects of vasopressin on maintenance of an active avoidance response in rats.

Authors:  A R King; D de Wied
Journal:  J Comp Physiol Psychol       Date:  1974-06

8.  Nuclear magnetic resonance studies of lysine-vasopressin: structural constraints.

Authors:  P H Von Dreele; A I Brewster; F A Bovey; H A Scheraga; M F Ferger; V Du Vigneaud
Journal:  Proc Natl Acad Sci U S A       Date:  1971-12       Impact factor: 11.205

9.  Conformational studies on tocinamide and deaminotocinamide by 220 MHz nuclear magnetic resonance spectroscopy.

Authors:  A I Brewster; J A Glasel; V J Hruby
Journal:  Proc Natl Acad Sci U S A       Date:  1972-06       Impact factor: 11.205

10.  Regulation of formation and proposed structure of the factor inhibiting the release of melanocyte-stimulating hormone.

Authors:  M E Celis; S Taleisnik; R Walter
Journal:  Proc Natl Acad Sci U S A       Date:  1971-07       Impact factor: 11.205

View more
  8 in total

Review 1.  Concepts for biologically active peptides.

Authors:  Abba J Kastin; Weihong Pan
Journal:  Curr Pharm Des       Date:  2010-10       Impact factor: 3.116

Review 2.  Vasopressin and alcohol: a multifaceted relationship.

Authors:  Kathryn M Harper; Darin J Knapp; Hugh E Criswell; George R Breese
Journal:  Psychopharmacology (Berl)       Date:  2018-11-03       Impact factor: 4.530

3.  Inhibition by Z-Pro-D-Leu of development of tolerance to and physical dependence on morphine in mice.

Authors:  R Walter; R F Ritzmann; H N Bhargava; T C Rainbow; L B Flexner; W A Krivoy
Journal:  Proc Natl Acad Sci U S A       Date:  1978-09       Impact factor: 11.205

4.  Immunocytochemistry of magnocellular neurons of supraoptic and paraventricular nuclei of normal and Brattleboro rats with vasopressin anti-idiotype antibody.

Authors:  K M Knigge; D T Piekut; D J Berlove
Journal:  Cell Tissue Res       Date:  1986       Impact factor: 5.249

5.  Two classes of arginine vasopressin binding sites on rat brain membranes.

Authors:  J T Junig; L G Abood; A M Skrobala
Journal:  Neurochem Res       Date:  1985-09       Impact factor: 3.996

Review 6.  Neuropeptides: animal behaviour and human psychopathology.

Authors:  D de Wied; J M van Ree
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1989

7.  Prolyl-leucyl-glycinamide, cyclo(leucylglycine), and derivatives block development of physical dependence on morphine in mice.

Authors:  R Walter; R F Ritzmann; H N Bhargava; L B Flexner
Journal:  Proc Natl Acad Sci U S A       Date:  1979-01       Impact factor: 11.205

8.  Modification of conditioned behavior of rats by neurohypophyseal hormones and analogues.

Authors:  R Walter; J M van Ree; D de Wied
Journal:  Proc Natl Acad Sci U S A       Date:  1978-05       Impact factor: 11.205

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.